KRAS mutated Non-Small Lung Carcinoma: A Real World Context from the Indian subcontinent.

Ullas BatraShrinidhi NathanyMansi SharmaAmrith BpJoslia T JoseHarkirat SinghSakshi MattooAnurag Mehta

Published in: Cancer medicine (2022)

This is the largest single-center experience from the Indian subcontinent for KRAS-mutated NSCLC with distinct clinical features. It highlights the unmet need for G12C inhibitors in our country, where prevalence is equivalent to the West.

Keyphrases

wild type
small cell lung cancer
risk factors
brain metastases
tyrosine kinase